NCT02018133View on ClinicalTrials.gov

Identification of Markers for Determining the Efficacy of Vitamin D Receptor Activator Therapy in Stage 3/4 CKD Patients

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
CKD Stage 3/4
Interventions
DRUG

Vitamin D 2mg daily for 2 weeks oral paricalcitol

vitamin D 2 capsules daily

DRUG

Placebo

placebo 2 capsule daily

Trial Locations (1)

60612

University of Illinois at Chicago, Chicago

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

University of Illinois at Chicago

OTHER